• Entinostat: From HDAC Mechanism to Translation

  2026-09-01

  Entinostat (MS-275, SNDX-275) illustrates why epigenetic drug development must connect target engagement with the biology of growth arrest and cell death. This translational perspective shows how to design more informative assays, position a selective class I HDAC inhibitor against broader approaches, and interpret preclinical and clinical evidence without overstating what any single endpoint can prove.

• Chloramphenicol as a Plasmid Tracking Tool

  2026-09-01

  Chloramphenicol is more than a selection antibiotic: it can help researchers interpret plasmid maintenance, transfer, and assay bias. This article connects its molecular mechanism with the multi-method resistance surveillance strategy used in recent CREC research.

• HBsAg Hijacks TBK1 to Suppress Interferon

  2026-08-31

  A 2025 Cell Death and Disease study shows that hepatitis B surface antigen (HBsAg) uncouples TBK1 activation from IRF3 signaling, thereby suppressing type I interferon while promoting incomplete autophagy and HBV replication. The work identifies TBK1 dimerization, p62 phosphorylation, and SNAP29-dependent autophagosome–lysosome fusion as mechanistic links between immune evasion and viral persistence.

• Sulfo-Cy3 NHS Ester for Vascular Assays

  2026-08-31

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for designing protein-labeling assays around ischemic vascular remodeling. This article translates the AIBP–LRP2–HDL–miR-223 findings into practical, mechanistically disciplined fluorescence workflows.

• Disulfiram: From ALDH2 to Cancer Assays

  2026-08-30

  Disulfiram is a dopamine β-hydroxylase inhibitor and multifunctional research compound linking ALDH2 inhibition to genotype-selective cancer vulnerability. This article translates APC-deficient colorectal cancer findings into practical assay design while distinguishing ROS signaling from proteasome-based mechanisms.

• Nurr1+ Neuron Development in the Rat Claustrum

  2026-08-29

  Fang, Wang, and Naumann mapped the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. By combining EdU birth dating with Nurr1 in situ hybridization, the study identified sequential neurogenesis and spatial gradients that refine how claustral subregions are defined during development.

• Halazone: An Evidence Map for Dual-Use Assays

  2026-08-28

  Halazone is an antimicrobial sulfonamide derivative with distinct water-disinfection and neurophysiological research roles. This evidence-mapping guide explains how redox chemistry, membrane effects, controls, and storage determine whether an experiment produces an interpretable result.

• Thymoquinone and Doxorubicin Cardiotoxicity

  2026-08-28

  A 2025 study found that thymoquinone protected mice from doxorubicin-associated cardiac injury, with evidence implicating Nrf2/HO-1 activation, improved redox balance, reduced ferroptosis-related changes, and preservation of mitochondrial structure. The work provides a mechanistic preclinical framework for studying cardioprotective interventions, while leaving dose translation, tumor-treatment compatibility, and human relevance unresolved.

• Autophagy–Liver Metastasis Signature in CRC

  2026-08-27

  Bai et al. developed a six-gene prognostic signature that integrates autophagy and liver-metastasis biology in colorectal cancer using bulk and single-cell transcriptomic data. The model stratified prognosis and was associated with an immunosuppressive microenvironment, T-cell exhaustion, macrophage remodeling, and potential immunotherapy resistance.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-27

  The reference study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-driven mitotic checkpoint complex disassembly. By combining HeLa cell extracts, purified proteins, kinase assays, and an S102A mutant, the authors show that Plk1 phosphorylation restrains p31comet and may prevent premature checkpoint turnover during active mitosis.

• AP2-M to Interaction Evidence in Babesia

  2026-08-26

  A translational framework for extending AP2-M regulatory biology in Babesia from genomic occupancy and transcriptomic evidence toward experimentally testable protein-complex hypotheses using magnetic immunoprecipitation.

• CUDC-907: Practical PI3K/HDAC Workflow Guide

  2026-08-26

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, histone deacetylase activity, apoptosis, and cell-cycle regulation. This guide covers formulation, starting treatment conditions, assay controls, and interpretation limits; the compound is for scientific research only and should not be used diagnostically or clinically.

• 3-Hydroxybutyrate (BHBA) in Cell Assays

  2026-08-25

  Learn how 3-hydroxybutyrate (BHBA), SKU M1297, can be incorporated into reproducible cell viability, metabolic-stress, and ferroptosis workflows. This scenario-based guide links assay design, solution handling, data interpretation, and vendor selection to current ketone-body evidence.

• Propidium Iodide Workflows for Cell Analysis

  2026-08-25

  Build more reliable viability, apoptosis, and cell-cycle experiments with Propidium iodide, a membrane-exclusion DNA intercalating dye suited to microscopy and flow cytometry. A lactoferrin heating study offers a useful process-control lesson: match the treatment history, then use PI as a standardized functional endpoint rather than as a stand-alone mechanistic readout.

• Protease and Phosphatase Inhibitor Cocktail Guide

  2026-08-24

  K4006 helps limit proteolysis and dephosphorylation during biological sample extraction by combining broad protease and phosphatase inhibition in an EDTA-free, 100X aqueous format. It is intended for controlled lysis workflows, but it should not be treated as universal protection against every enzyme or as a substitute for buffer compatibility and assay-specific validation.

8518 records 7/568 page Previous Next First page 上5页 678910 下5页 Last page